Éric A. Cohen (born March 19, 1958) is a Canadian molecular virologist whose research is focused on human immunodeficiency virus (HIV)-host interactions that govern viral replication and persistence.
[5] In 1986, he joined the laboratory of William A. Haseltine at the Dana–Farber Cancer Institute and Harvard Medical School as a postdoctoral fellow, working on fundamental aspects of HIV structure and function to uncover new targets for antiviral therapy.
[6] In 1990, Cohen became a faculty member of the Department of Microbiology, Infectiology and Immunology at Université de Montréal and was appointed Professor of Virology in 1999.
[30][31][32][33] Cohen is a founding member of the AIDS and Infectious Disease Network (SIDA-MI) of the Fonds de recherche du Québec – Santé (FRQS), and currently serves on its scientific committee.
[44] He was a scientific advisor and collaborator for Theratechnologies, a Canadian biotechnology company that developed Egrifta, the only treatment indicated to reduce excess abdominal fat in HIV-infected patients with lipodystrophy.